Toxicity of volcanic-ash leachate to a blue-green alga. Results of a preliminary bioassay experiment.

D. McKnight,G. Feder,E. A. Stiles

DOI: https://doi.org/10.1021/es00085a606

1981-03-01

Abstract:

What problem does this paper attempt to address?

Sarcoidosis mortality in Sweden: a population-based cohort study

Marios Rossides,Susanna Kullberg,Johan Askling,Anders Eklund,Johan Grunewald,Elizabeth V. Arkema

DOI: https://doi.org/10.1183/13993003.01815-2017

IF: 24.3

2018-02-01

European Respiratory Journal

Abstract:We aimed to investigate sarcoidosis mortality in a large, population-based cohort, taking into account disease heterogeneity. Individuals with incident sarcoidosis (n=8207) were identified from the Swedish National Patient Register using International Classification of Disease codes (2003‒2013). In a subset, cases receiving treatment ±3 months from diagnosis were identified from the Prescribed Drug Register. Nonsarcoidosis comparators from the general population were matched to cases 10:1 on birth year, sex and county. Individuals were followed for all-cause death in the Cause of Death Register. Adjusted mortality rates, rate differences and hazard ratios (HRs) were estimated, stratifying by age, sex and treatment status. The mortality rate was 11.0 per 1000 person-years in sarcoidosis versus 6.7 in comparators (rate difference 2.7 per 1000 person-years). The HR for death was 1.61 (95% CI 1.47‒1.76), with no large variation by age or sex. For cases not receiving treatment within the first 3 months, the HR was 1.13 (95% CI 0.94‒1.35). The HR was 2.34 (95% CI 1.99‒2.75) for those receiving treatment. Individuals with sarcoidosis are at a higher risk of death compared to the general population. For the majority, the increased risk is small. However, patients whose disease leads to treatment around diagnosis have a two-fold increased risk of death. Future interventions should focus on this vulnerable group.

respiratory system
Heart failure in first‐ and second‐generation immigrants aged 18–54 years in Sweden: A national study

Per Wändell,Xinjun Li,Axel C. Carlsson,Jan Sundquist,Kristina Sundquist

DOI: https://doi.org/10.1002/ehf2.14998

2024-07-26

ESC Heart Failure

Abstract:Purpose We aimed at analysing the risk of congestive heart failure (CHF) among first‐ and second‐generation immigrants in younger age groups. Methods All individuals aged 18–54 years, n = 3 973 454 in the first‐generation study and n = 3 817 560 in the second‐generation study, were included. CHF was defined as at least one registered diagnosis in the National Patient Register between 1 January 1998 and 31 December 2018. Cox regression analysis was used to estimate the relative risk [hazard ratios (HRs) with 99% confidence intervals (CIs)] of incident CHF with adjustments for age, co‐morbidities and socio‐demographics. Results In the first‐generation study, a total of 85 719 cases of CHF were registered, 54 369 men and 31 350 women, where fully adjusted models showed HRs for all foreign‐born men of 1.12 (99% CI 1.06–1.17) and for women of 0.99 (0.92–1.05). Groups with higher risk included men from Eastern Europe, Central Europe, Africa and Asia and women from Africa and Asia, and a lower risk was found among Latin American women. In the second‐generation study, a total of 88 999 cases of CHF were registered, 58 403 men and 30 596 women, where fully adjusted models showed HRs for second‐generation men of 1.04 (0.99–1.09) and women of 0.97 (0.90–1.04). Conclusions The higher risk in some foreign‐born groups needs to be paid attention to in clinical practice. The fact that almost all increased risks were attenuated and absent in second‐generation immigrants suggests that lifestyle and environmental factors are more important than genetic differences in the risk of CHF.

cardiac & cardiovascular systems
The risk of hemochromatosis among first- and second-generation immigrants: a cohort study of the total population in Sweden

Per Wändell,Xinjun Li,Axel C Carlsson,Jan Sundquist,Kristina Sundquist

DOI: https://doi.org/10.48101/ujms.v129.10376

2024-08-09

Abstract:Purpose: We aimed to analyze the risk of hereditary hemochromatosis (HH) among first-generation and second-generation immigrants in Sweden using Swedish-born individuals and Swedish-born individuals with Swedish-born parents as referents, respectively. Methods: All individuals aged 18 years of age and older, n = 6,180,500 in the first-generation study, and n = 4,589,930 in the second-generation study were included in the analyses. HH was defined as at least one registered diagnosis International Classification of Diseases 10th edition (E83.1) in the National Patient Register between January 1, 1998 and December 31, 2018. Cox regression was used to estimate the hazard ratios (HRs) with 99% confidence intervals (CI) owing to multiple testing, of incident HH with adjustments for age, cancer, other comorbidities, and socio-demographics. Results: In the first-generation study, there were 5,112 cases of HH, and in the second-generation study 4,626 cases of HH. The adjusted HRs for first-generation men and women overall were 0.72 (99% CI: 0.63-0.82) and 0.61 (99% CI: 0.52-0.72), respectively, and for the second-generation men and women 0.72 (99% CI: 0.62-0.83) and 0.97 (99% CI: 0.83-1.14), respectively, with a higher risk found only among first-generation men from Western Europe, HR 1.47 (99% CI: 1.05-2.06), compared to the control group. Conclusions: Our findings indicate that the overall risk of HH was lower among both first-generation and second-generation immigrants when compared to individuals born in Sweden or with Swedish-born parents. An elevated risk for HH was observed exclusively among first-generation men originating from Western Europe. These findings represent new knowledge and should be of global interest.
Risk and predictors of heart failure in sarcoidosis in a population-based cohort study from Sweden

Marios Rossides,Susanna Kullberg,Johan Grunewald,Anders Eklund,Daniela Di Giuseppe,Johan Askling,Elizabeth V Arkema

DOI: https://doi.org/10.1136/heartjnl-2021-319129

IF: 5.7

2021-05-21

Heart

Abstract:Objectives Previous studies showed a strong association between sarcoidosis and heart failure (HF) but did not consider risk stratification or risk factors to identify useful aetiological insights. We estimated overall and stratified HRs and identified risk factors for HF in sarcoidosis. Methods Sarcoidosis cases were identified from the Swedish National Patient Register (NPR; ≥2 International Classification of Diseases-coded visits, 2003–2013) and matched to general population comparators. They were followed for HF in the NPR. Treated were cases who were dispensed ≥1 immunosuppressant ±3 months from the first sarcoidosis visit (2006–2013). Using Cox models, we estimated HRs adjusted for demographics and comorbidity and identified independent risk factors of HF together with their attributable fractions (AFs). Results During follow-up, 204 of 8574 sarcoidosis cases and 721 of 84 192 comparators were diagnosed with HF (rate 2.2 vs 0.7/1000 person-years, respectively). The HR associated with sarcoidosis was 2.43 (95% CI 2.06 to 2.86) and did not vary by age, sex or treatment status. It was higher during the first 2 years after diagnosis (HR 3.7 vs 1.9) and in individuals without a history of ischaemic heart disease (IHD; HR 2.7 vs 1.7). Diabetes, atrial fibrillation and other arrhythmias were the strongest independent clinical predictors of HF (HR 2.5 each, 2-year AF 20%, 16% and 12%, respectively). Conclusions Although low, the HF rate was more than twofold increased in sarcoidosis compared with the general population, particularly right after diagnosis. IHD history cannot solely explain these risks, whereas ventricular arrhythmias indicating cardiac sarcoidosis appear to be a strong predictor of HF in sarcoidosis.

cardiac & cardiovascular systems
Cancer mortality by country of birth and cancer type in Sweden: A 25‐year registry‐based cohort study

Daniel Nigusse Tollosa,Kazem Zendehdel,Alessandro Procopio,Agneta Cederström,Paolo Boffetta,Eero Pukkala,Mikael Rostila

DOI: https://doi.org/10.1002/cam4.70020

IF: 4.711

2024-07-19

Cancer Medicine

Abstract:Numerous studies have reported lower overall cancer mortality rates among immigrants compared to native populations. However, limited information exists regarding cancer mortality among immigrants based on specific birth countries and cancer types. We used population‐based registries and followed 10 million individuals aged 20 years or older in Sweden between 1992 and 2016. The Cox proportional hazard model was used to explore the disparities in cancer mortality by country of birth and cancer type, stratified by gender. Age‐standardized mortality rates were also computed using the world standard population. Hazard ratio (HR) of all‐site cancer was slightly lower among immigrants (males: HRm = 0.97: 95% confidence interval: 0.95, 0.98; females: HRf = 0.93: 0.91, 0.94) than Swedish‐born population. However, the immigrants showed higher mortality for infection‐related cancers, including liver (HRf = 1.10: 1.01, 1.19; HRm = 1.10: 1.02, 1.17), stomach (HRf = 1.39: 1.31, 1.49; HRm = 1.33: 1.26, 1.41) cancers, and tobacco‐related cancers, including lung (HRm = 1.44: 1.40, 1.49), and laryngeal cancers (HRm = 1.47: 1.24, 1.75). The HR of mesothelioma was also significantly higher in immigrants (HRf = 1.44: 1.10, 1.90). Mortality from lung cancer was specifically higher in men from Nordic (HRm = 1.41: 1.27, 1.55) and non‐Nordic Europe (HRm = 1.49: 1.43, 1.55) countries and lower in Asian (HRm = 0.78: 0.66, 0.93) and South American men (HRm = 0.70: 0.57, 0.87). In conclusion, there are large variations in cancer mortality by country of birth, and cancer type and require regular surveillance. Our detailed analyses lead to some novel findings such as excess mortality rate of mesothelioma and laryngeal cancers in Immigrants in Sweden. A targeted cancer prevention program among immigrants in Sweden is needed.

oncology
COVID-19 mortality among immigrants by duration of residence in Sweden: a population-based cohort study

Sol P Juárez,Enrico Debiasi,Matthew Wallace,Sven Drefahl,Eleonora Mussino,Agneta Cederström,Mikael Rostila,Siddartha Aradhya,Sol P. Juárez

DOI: https://doi.org/10.1177/14034948241244560

2024-04-11

Scandinavian Journal of Public Health

Abstract:Scandinavian Journal of Public Health, Ahead of Print. Background:Explanations for the disproportional COVID-19 burden among immigrants relative to host-country natives include differential exposure to the virus and susceptibility due to poor health conditions. Prior to the pandemic, immigrants displayed deteriorating health with duration of residence that may be associated with increased susceptibility over time. The aim of this study was to compare immigrant–native COVID-19 mortality by immigrants' duration of residence to examine the role of differential susceptibility.Methods:A population-based cohort study was conducted with individuals between 18 and 100 years old registered in Sweden between 1 January 2015 and 15 June 2022. Cox regression models were run to estimate hazard ratios (HRs) and 95% confidence intervals (CIs).Results:Inequalities in COVID-19 mortality between immigrants and the Swedish-born population in the working-age group were concentrated among those of non-Western origins and from Finland with more than 15 years in Sweden, while for those of retirement age, these groups showed higher COVID-19 mortality HRs regardless of duration of residence. Both age groups of immigrants from Africa and the Middle East showed consistently higher COVID-19 mortality HRs. For the working-age population: Africa: HR<15: 2.46, 95%CI: 1.78, 3.38; HR≥15: 1.49, 95%CI: 1.01, 2.19; and from the Middle East: HR<15: 1.20, 95%CI: 0.90, 1.60; HR≥15: 1.65, 95%CI: 1.32, 2.05. For the retirement-age population: Africa: HR<15: 3.94, 95%CI: 2.85, 5.44; HR≥15: 1.66, 95%CI: 1.32, 2.09; Middle East: HR<15: 3.27, 95%CI: 2.70, 3.97; HR≥15: 2.12, 95%CI: 1.91, 2.34.Conclusions:Differential exposure, as opposed to differential susceptibility, likely accounted for the higher COVID-19 mortality observed among those origins who were disproportionately affected by the pandemic in Sweden.

public, environmental & occupational health
National retrospective registry survey on the epidemiology of sarcoidosis in Finland 2002-2022

Johanna Salonen,Riitta Kaarteenaho

DOI: https://doi.org/10.1136/bmjresp-2024-002461

2024-08-21

Abstract:Background: The prevalence of sarcoidosis is known to be high in the Nordic countries. There are no recent research data on the incidence or prevalence of sarcoidosis in Finland. Our aim was to investigate the epidemiology of sarcoidosis in Finland through a retrospective registry-based study. Methods: We made an information request to the Hilmo database on patients who had been treated in Finnish specialised care with a main diagnosis related to sarcoidosis. Data were requested for the period 1 January-31 December for the years 2002, 2012 and 2022. In addition, we examined the age and gender distribution and regional differences in these variables between the five university hospital districts covering the whole of Finland. Results: The incidence of sarcoidosis was 17‒19/100 000/year throughout the follow-up period. The prevalence of sarcoidosis in the ≥18-year-old population had risen from 85/100 000 in 2002-106/100 000 in 2022. There were considerable differences between university hospital districts: The highest prevalence rate was 170/100 000 in the Tampere University Hospital district in 2022, which was twice as high as in the Helsinki University Hospital district (84/100 000). The proportion of pulmonary sarcoidosis in all sarcoidosis cases decreased from 62% to 45% while the proportion of multiorgan sarcoidosis (D86.8) increased from 11% to 34%. The incidence of sarcoidosis was 15/100 000 and the prevalence was 82/100 000 in the age groups of ≥60 years in 2002. In 2022, the incidence in this same age group had risen to 20/100 000 and the prevalence to 109/100 000. In the ≥60-year-old population, the proportion of D86.8 increased from 11% to 35%. Conclusions: Sarcoidosis was a more common disease in Finland than in previous studies. Multiorgan sarcoidosis among the elderly has increased over the past 20 years. This might be explained by changes in environmental factors associated with sarcoidosis. Significant regional differences in prevalence might be partly explained by familial clustering.
Closer Scientific Contact with Czechoslovakia.

F. Went

DOI: https://doi.org/10.1126/SCIENCE.132.3424.380

IF: 56.9

1960-08-12

Science

Abstract:
Melatonergic Drugs in Clinical Practice

R. Hardeland,B. Poeggeler,V. Srinivasan,Ilya Trakht,S. Pandi‑Perumal,D. Cardinali

DOI: https://doi.org/10.1055/s-0031-1296459

2008-01-01

Abstract:Abstract Melatonin (CAS 73-31-4) has both hypnotic and sleep/wake rhythm regulating properties. These sleep promoting actions, which are already demonstrable in healthy humans, have been found useful in subjects suffering from circadian rhythm sleep disorders (CRSD) like delayed sleep phase syndrome (DSPS), jet lag and shift-work sleep disorder. Low nocturnal melatonin production and secretion have been documented in elderly insomniacs, and exogenous melatonin has been shown to be beneficial in treating sleep disturbances of these patients. In comparison to a number of sleep-promoting compounds that are usually prescribed, such as benzodiazepines and z-drugs (Zolpidem and Zopiclon belonging to the latter ones), melatonin has several advantages of clinical value: it does not cause hangover nor withdrawal effects and is devoid of any addictive potential. However, recent meta-analyses revealed that melatonin is not sufficiently effective in treating most primary sleep disorders. Some of the reasons for a limited efficacy of this natural hormone are related to its extremely short half-life in the circulation, and to the fact that sleep maintenance is also regulated by mechanisms downstream of primary melatonergic actions. Hence, there is an urgent need for the development of melatonin receptor agonists with a longer half-life, which could be suitable for a successful treatment of insomnia. Such requirements are fulfilled by ramelteon (CAS 196597-26-9), which possesses a high affinity for the melatonin receptors MT1 and MT2 present in the circadian pacemaker, the suprachiasmatic nucleus (SCN). Ramelteon also has a substantially longer half-life than melatonin. This new drug has been successfully used in treating elderly insomniacs without any adverse effects reported, and is promising for treating patients with primary insomnia and also those suffering from CRSD. Since sleep disturbances constitute the most prevalent symptoms of various forms of depression, the need for the development of an ideal antidepressant was felt, which would both improve sleep and mitigate depressive symptoms. Since most of the currently used antidepressants, including the selective serotonin re-uptake inhibitors worsen the sleep disturbances of depressive patients, another novel melatonergic drug, agomelatine (CAS 138112-76-2), holds some promise because of its particular combination of actions: it has a high affinity for MT1 and MT2 receptors in the SCN, but it acts additionally as a 5-HT2C antagonist [5-hydroxytryptamine (serotonin) receptor 2C antagonist]. The latter property, which is decisive for the antidepressive action, would not favor but potentially antagonize sleep, but this is overcome during night by the melatonergic, sleep-promoting effect. This drug has been found beneficial in treating patients with major depressive and seasonal affective disorders. Unlike the other antidepressants, agomelatine improves both sleep and clinical symptoms of depressive illness and does not have any of the side effects on sleep seen with other compounds in use. This property seems to be of particular value because of the aggravating effects of disturbed sleep in the development of depressive symptoms. Based on these facts, agomelatine seems to be a drug of superior efficacy with a promising future in the treatment of depressive disorders. However, long-term safety studies are required for both ramelteon and agomelatine, with a consideration of the pharmacology of their metabolites, their effects on redox metabolism, and of eventual undesired melaton-ergic effects, e. g., on reproductive functions. According to current data, both compounds seem to be safe during short-term treatment.
Search for the Decays B_{s}

R. Aaij,B. Adeva,M. Adinolfi,Z. Ajaltouni,S. Akar,J. Albrecht,F. Alessio,M. Alexander,S. Ali,G. Alkhazov,P. Cartelle,A. A. Alves,S. Amato,S. Amerio,Y. Amhis

Abstract:Using the CLEO-II data set we have searched for the Cabibbo-suppressed decays B0 → D(∗)+ D(∗)−. For the decay B0 → D∗+ D, we observe one candidate signal event, with an expected background of 0.022 ± 0.011 events. This yield corresponds to a branching fraction of B(B0→D∗+ D) = (5.3 −3.7(stat) ± 1.0(syst)) × 10 −4 and an upper limit of B(B0→D∗+ D) < 2.2 × 10−3 at the 90% CL. For B0 → D D and B0 → D+ D, no significant excess of signal above the expected background level is seen, and we calculate the 90% CL upper limits on the branching fractions to be B(B0→D∗± D) < 1.8 × 10−3 and B(B0→D+ D) < 1.2 × 10−3. SLAC-PUB-9789 hep-ex/9704014 Stanford Linear Accelerator Center, Stanford University, Stanford, CA 94309, USA Work supported in part by Department of Energy Contract DE-AC03-76SF00515 Submitted to Physical Review Letters D. M. Asner, D. W. Bliss, W. S. Brower, G. Masek, H. P. Paar, V. Sharma, J. Gronberg, R. Kutschke, D. J. Lange, S. Menary, R. J. Morrison, H. N. Nelson, T. K. Nelson, C. Qiao, J. D. Richman, D. Roberts, A. Ryd, M. S. Witherell, R. Balest, B. H. Behrens, K. Cho, W. T. Ford, H. Park, P. Rankin, J. Roy, J. G. Smith, J. P. Alexander, C. Bebek, B. E. Berger, K. Berkelman, K. Bloom, D. G. Cassel, H. A. Cho, D. M. Coffman, D. S. Crowcroft, M. Dickson, P. S. Drell, K. M. Ecklund, R. Ehrlich, R. Elia, A. D. Foland, P. Gaidarev, B. Gittelman, S. W. Gray, D. L. Hartill, B. K. Heltsley, P. I. Hopman, J. Kandaswamy, N. Katayama, P. C. Kim, D. L. Kreinick, T. Lee, Y. Liu, G. S. Ludwig, J. Masui, J. Mevissen, N. B. Mistry, C. R. Ng, E. Nordberg, M. Ogg, J. R. Patterson, D. Peterson, D. Riley, A. Soffer, C. Ward, M. Athanas, P. Avery, C. D. Jones, M. Lohner, C. Prescott, S. Yang, J. Yelton, J. Zheng, G. Brandenburg, R. A. Briere, Y.S. Gao, D. Y.-J. Kim, R. Wilson, H. Yamamoto, T. E. Browder, F. Li, Y. Li, J. L. Rodriguez, T. Bergfeld, B. I. Eisenstein, J. Ernst, G. E. Gladding, G. D. Gollin, R. M. Hans, E. Johnson, I. Karliner, M. A. Marsh, M. Palmer, M. Selen, J. J. Thaler, K. W. Edwards, A. Bellerive, R. Janicek, D. B. MacFarlane, K. W. McLean, P. M. Patel, A. J. Sadoff, R. Ammar, P. Baringer, A. Bean, D. Besson, D. Coppage, C. Darling, R. Davis, N. Hancock, S. Kotov, I. Kravchenko, N. Kwak, S. Anderson, Y. Kubota, M. Lattery, J. J. O’Neill, S. Patton, R. Poling, T. Riehle, V. Savinov, A. Smith, M. S. Alam, S. B. Athar, Z. Ling, A. H. Mahmood, H. Severini, S. Timm, F. Wappler, A. Anastassov, S. Blinov, J. E. Duboscq, K. D. Fisher, D. Fujino, R. Fulton, K. K. Gan, T. Hart, K. Honscheid, H. Kagan, R. Kass, J. Lee, M. B. Spencer, M. Sung, A. Undrus, R. Wanke, A. Wolf, M. M. Zoeller, B. Nemati, S. J. Richichi, W. R. Ross, P. Skubic, M. Wood, M. Bishai, J. Fast, E. Gerndt, J. W. Hinson, N. Menon, D. H. Miller, E. I. Shibata, I. P. J. Shipsey, M. Yurko, L. Gibbons, S. D. Johnson, Y. Kwon, S. Roberts, E. H. Thorndike, C. P. Jessop, K. Lingel, H. Marsiske, M. L. Perl, S. F. Schaffner, D. Ugolini, R. Wang, X. Zhou, T. E. Coan, V. Fadeyev, I. Korolkov, Y. Maravin, I. Narsky, V. Shelkov, J. Staeck, R. Stroynowski, I. Volobouev, J. Ye, M. Artuso, A. Efimov, F. Frasconi, M. Gao, M. Goldberg, D. He, S. Kopp, G. C. Moneti, R. Mountain, Y. Mukhin, S. Schuh, T. Skwarnicki, S. Stone, G. Viehhauser, X. Xing, J. Bartelt, S. E. Csorna, V. Jain, S. Marka, A. Freyberger, R. Godang, K. Kinoshita, I. C. Lai, P. Pomianowski, S. Schrenk, G. Bonvicini, D. Cinabro, R. Greene, L. P. Perera, B. Barish, M. Chadha, S. Chan, G. Eigen, J. S. Miller, C. O’Grady, M. Schmidtler, J. Urheim, A. J. Weinstein, and F. Würthwein 1University of California, San Diego, La Jolla, California 92093 Permanent address: University of Texas, Austin TX 78712 Permanent address: BINP, RU-630090 Novosibirsk, Russia. Permanent address: Lawrence Livermore National Laboratory, Livermore, CA 94551.
COVID-19: incidence and mortality in Sweden comparing all foreign-born to all Swedish-born individuals in different occupations in an unvaccinated cohort of year 2020

Martin Tondel,Tobias Nordquist,Magnus Helgesson,Magnus Svartengren

DOI: https://doi.org/10.1136/oemed-2023-108952

IF: 4.9

2024-03-10

Occupational and Environmental Medicine

Abstract:Objectives The aim was to analyse the incidence and mortality of COVID-19 in immigrants compared with Swedish born in inpatients and outpatient registers, respectively. Methods The study population included all persons 20–88 years of age living in Sweden, 31 December 2019, including 1 676 516 foreign-born persons and 6 037 151 Swedish-born persons. The outcome was clinical cases of COVID-19 with a positive PCR test (ICD-10 U07.01) or without a positive PCR test (U07.2) from 1 January to 31 December 2020. Persons 20–64 years of age were classified with occupational titles according to the Swedish Standard Classification of Occupations. Residing municipality of each individual was coded according to the Swedish Association of Local Authorities. Relative risks (RR) were calculated by sex in 5 years age bands using Swedish born as reference. Age-adjusted RRs (adj RR) with 95% CIs were calculated in a Poisson regression model. Rural municipalities were used as the reference category. Results Foreign born had consistently higher RRs in COVID-19, regardless of sex, with a peak in 50–69 years of age. Foreign born had a higher RR of death in COVID-19 above 50 years and 40 years of age in women and men, respectively. Among occupations, male drivers had the highest adj RR 4.37 (95% CI 3.45 to 5.54) and 5.09 (4.26 to 6.07) in outpatients and inpatients, respectively (U07.1). Persons living in commuting municipalities did not show any consistent increased risk for COVID-19. Conclusion Foreign born have a higher risk of COVID-19 compared with Swedish-born individuals at any age and occupation before vaccination began in 2021.

public, environmental & occupational health
Bilayer bending elasticity measured by Fourier analysis of thermally excited surface undulations of flaccid vesicles

H. Engelhardt,H. Duwe,E. Sackmann

DOI: https://doi.org/10.1051/JPHYSLET:01985004608039500

1985-04-01

Abstract:We measure the bending elasticity of flaccid vesicles by Fourier analysis of the thermally excited surface undulations up to the 8th order. The results are explained in terms of the recent theory of Schneider et al. The value of the bending elastic constant for fluid lecithin bilayers (K c =4×10 −13 erg) agrees well with that of erythrocyte membranes but is nearly an order of magnitude smaller than that reported for the same lipid in the literature. This discrepancy is attributed to the fact that the K c value obtained by considering the lowest order mode of deformation alone is systematically too high Nous mesurons l'elasticite de flexion de vesicules flasques par l'analyse de Fourier des ondulations thermiques de surface, jusqu'au 8eme ordre. Les resultats sont expliques par la theorie recente de Schneider et al. La constante elastique de flexion pour une bicouche fluide de lecithine (K c =4×10 −13 erg) est en bon accord avec celle des membranes d'erythrocytes, mais est presque d'un ordre de grandeur plus faible que celle donnee pour les memes lipides dans la litterature. Ce desaccord est attribue au fait que la valeur de K c obtenue en ne considerant que le mode fondamental de deformation est systematiquement trop elevee
Identifying sarcoidosis trends using web search and real-world data in Sweden: a retrospective longitudinal study

Stefanie Ziehfreund,Linda Tizek,Elizabeth V Arkema,Alexander Zink

DOI: https://doi.org/10.1038/s41598-024-69223-8

2024-08-20

Abstract:Web search data are associated with disease incidence, population interest, and seasonal variations. This study aimed to investigate seasonal and geographical variations of web search data for sarcoidosis and to explore its association with external factors and sarcoidosis incidence in Sweden. Therefore, sarcoidosis-related data from Google Ads Keyword Planer (2017-2020) were generated for Sweden according to its 21 counties. The relationship between search volume and season, region, population demographics, environmental factors, and the sarcoidosis incidence listed in the National Patient Register was assessed. Analyses revealed seasonal variations for Sweden with an overall peak in the spring and autumn. Geographical differences were observed, with a higher search volume for north-western counties and the lowest search volume for Stockholm County. At the country level, the search volume was positively associated with the sarcoidosis incidence. Higher male proportion and older mean age were associated with a higher search volume, while a higher proportion of foreign-born residents, humidity, and mean temperature were associated with a lower search volume. Our analyses detected correlations between web search data, sarcoidosis incidence, and external factors. Analyses of sarcoidosis web search data therefore appear to be a valuable approach to disease surveillance to address medical needs and public interest.
Inflammatory plasma protein levels are elevated years before sarcoidosis diagnosis: a nested case-control study in Sweden

Elizabeth V Arkema,Michael C Sachs,Annica Dominicus,Anders Eklund,Anna Smed-Sörensen,Johan Grunewald,Anders Blomberg

DOI: https://doi.org/10.1183/13993003.00277-2024

2024-09-26

Abstract:Sarcoidosis is an immune-mediated inflammatory disease whose natural development is not well understood. We aimed to determine if inflammatory plasma protein levels are elevated before sarcoidosis diagnosis compared to controls. Furthermore, we investigated which proteins are increased and how long before diagnosis they are increased. Cases with sarcoidosis and controls matched 2:1 on sex, birthdate, subcohort and sample date were identified in the Northern Sweden Health and Disease Study to perform a nested case-control study. Cases were validated and included if they provided ≥1 plasma sample ≥2 years before sarcoidosis diagnosis. Plasma protein levels were measured using the Olink Inflammation panel and expressed in Normalized Protein eXpression values. Unconditional logistic regression models adjusted for age, sex, subcohort and time since sampling were used to estimate log odds ratios with 95% confidence intervals for each protein overall and by time to diagnosis. p-values were adjusted for multiple comparisons using the Benjamini-Hochberg method. We included 152 cases and 341 controls. Mean time between sample and sarcoidosis diagnosis was 13.4 years. Forty-four proteins were significantly elevated prior to sarcoidosis compared to controls in multivariable-adjusted analyses. The ten proteins with the lowest p-values were CCL3, CCL19, CDCP1, CXCL9, CXCL10, IFNγ, IL-12B, MCP-3, TNF, and TNFRSF9. Fewer proteins were associated with sarcoidosis in samples taken longer before diagnosis. Restricting to samples taken ≥10 years prior to sarcoidosis diagnosis, 27 proteins remained statistically significant. Several inflammatory proteins were elevated in plasma many years before sarcoidosis onset compared to controls, revealing a preclinical phase characterised by inflammation.
Mortality differentials by immigrant groups in Sweden: the contribution of socioeconomic position.

M. Rostila,J. Fritzell

DOI: https://doi.org/10.2105/AJPH.2013.301613

2014-03-12

American Journal of Public Health

Abstract:OBJECTIVES We studied mortality differentials between specific groups of foreign-born immigrants in Sweden and whether socioeconomic position (SEP) could account for such differences. METHODS We conducted a follow-up study of 1 997 666 men and 1 964 965 women ages 30 to 65 years based on data from national Swedish total population registers. We examined mortality risks in the 12 largest immigrant groups in Sweden between 1998 and 2006 using Cox regression. We also investigated deaths from all causes, circulatory disease, neoplasms, and external causes. RESULTS We found higher all-cause mortality among many immigrant categories, although some groups had lower mortality. When studying cause-specific mortality, we found the largest differentials in deaths from circulatory disease, whereas disparities in mortality from neoplasms were smaller. SEP, especially income and occupational class, accounted for most of the mortality differentials by country of birth. CONCLUSIONS Our findings stressed that different aspects of SEP were not interchangeable in relation to immigrant health. Although policies aimed at improving immigrants' socioeconomic conditions might be beneficial for health and longevity, our findings indicated that such policies might have varying effects depending on the specific country of origin and cause of death.

Sociology,Medicine
Metabolism and kinetics of the hypoglycemic agent glipizide in man--comparison with glibenclamide.

L. Fuccella,V. Tamassia,G. Valzelli

DOI: https://doi.org/10.1002/J.1552-4604.1973.TB00255.X

1973-02-03

The Journal of New Drugs

Abstract:
Menopausal hormone therapy and risk of sarcoidosis: a population-based nested case–control study in Sweden

Marina Dehara,Susanna Kullberg,Marie Bixo,Michael C. Sachs,Johan Grunewald,Elizabeth V. Arkema

DOI: https://doi.org/10.1007/s10654-023-01084-3

2024-01-13

European Journal of Epidemiology

Abstract:Sarcoidosis incidence peaks in women between 50 and 60 years old, which coincides with menopause, suggesting that certain sex hormones, mainly estrogen, may play a role in disease development. We investigated whether menopausal hormone therapy (MHT) was associated with sarcoidosis risk in women and whether the risk varied by treatment type. We performed a nested case–control study (2007–2020) including incident sarcoidosis cases from the Swedish National Patient Register (n = 2593) and matched (1:10) to general population controls (n = 20,003) on birth year, county, and living in Sweden at the time of sarcoidosis diagnosis. Dispensations of MHT were obtained from the Swedish Prescribed Drug Register before sarcoidosis diagnosis/matching. Adjusted odds ratios (aOR) of sarcoidosis were estimated using conditional logistic regression. Ever MHT use was associated with a 25% higher risk of sarcoidosis compared with never use (aOR 1.25, 95% CI 1.13–1.38). When MHT type and route of administration were considered together, systemic estrogen was associated with the highest risk of sarcoidosis (aOR 1.51, 95% CI 1.23–1.85), followed by local estrogen (aOR 1.25, 95% CI 1.11–1.42), while systemic estrogen-progestogen combined was associated with the lowest risk compared to never users (aOR 1.12, 95% CI 0.96–1.31). The aOR of sarcoidosis did not differ greatly by duration of MHT use. Our findings suggest that a history of MHT use is associated with increased risk of sarcoidosis, with women receiving estrogen administered systemically having the highest risk.

public, environmental & occupational health
Sarcoidosis and lymphoma mortality risk: An observational study from the Spanish National Registry

Víctor Moreno-Torres,María Martínez-Urbistondo,Pedro Durán-Del Campo,Pablo Tutor,Begoña Rodríguez,Raquel Castejón,Susana Mellor-Pita

DOI: https://doi.org/10.1016/j.jtauto.2024.100236

2024-02-19

Abstract:Introduction: Patients with sarcoidosis have a lower survival rate than the general population, in part due to cardiovascular disease, infections and neoplasms. Our objective was to evaluate the impact of haematological neoplasms (HN) and lymphomas on sarcoidosis patient mortality in a nation-wide analysis conducted in Spain, a country with a population of 47 million. Methods: Retrospective and observational comparison of the HN related deaths in sarcoidosis patients and the general Spanish population reported in the Spanish Hospital Discharge Database. To determine the impact of sarcoidosis on the risk of dying from each HN lineage, a binary logistic regression considering age, female sex, tobacco and alcohol consumption, was performed. Results: In the period 2016 and 2019, 139,531 in-hospital deaths from neoplasms were certified in Spain (77 in patients with sarcoidosis). Patients with sarcoidosis died at younger age than the general Spanish population (72.9 vs 77.6, p<0.001). Sarcoidosis patients presented a higher mortality risk from HN (20.8% vs 8.9%, p=0.001, OR=2.64, 95% CI 1.52-4.59), attributable to the higher proportion of deaths from non-Hodgkin lymphoma (NHL), (9.2% vs 2.9%, p=0.006, OR= 3.33, 95% CI 1.53-7.25) from both B cell (6.6% vs 2.5%, p=0.044, OR= 2.62, 95% 1.06-6.5) and T/NK cell lineages (2.6% vs 0.3%, p=0.024, OR= 7.88, 95% CI 1.92-32.29) as well as HN with uncertain behavior and myeloproliferative disorders (2.6% vs 0.3%, p=0.018, OR= 11.88, 95% CI 2.88-49.02). The mean age of sarcoidosis patients who died from HN (63.6 vs 71.9, p=0.032) and non-Hodgkin lymphoma (56.9 vs 71, p=0.009) was lower than that of the general population. Conclusion: Patients with sarcoidosis present a higher risk of premature death from HN, including NHL from B, T/NK cell lineage and myeloproliferative disorders in comparison with the general Spanish population. In addition to developing strategies that might help to attenuate their occurrence and impact, such as decreasing the immunosuppressive burden, specific early-detection programs for these conditions should be investigated and considered carefully.
Spondyloarthritis in first-degree relatives and spouses of patients with inflammatory bowel disease: A nationwide population-based cohort study from Sweden

Sarita Shrestha,Judith S Brand,Mehdi Osooli,Carl Eriksson,Ida Schoultz,Johan Askling,Tine Jess,Scott Montgomery,Ola Olén,Jonas Halfvarson

DOI: https://doi.org/10.1093/ecco-jcc/jjae041

2024-03-22

Journal of Crohn's and Colitis

Abstract:Abstract Background and Aims Register-based research suggests a shared pathophysiology between inflammatory bowel disease [IBD] and spondyloarthritis [SpA], but the role of familial [genetic and environmental] factors in this shared susceptibility is largely unknown. We compared the risk of SpA in first-degree relatives [FDRs] and spouses of IBD patients with FDRs and spouses of matched population-based reference individuals. Methods We identified 147,080 FDRs and 25,945 spouses of patients with incident IBD [N=39,203] during 2006-2016 and 1,453,429 FDRs and 258,098 spouses of matched reference individuals [N=390,490], by linking nationwide Swedish registers and gastrointestinal biopsy data. Study participants were followed 1987-2017. Cox regression was used to estimate hazard ratios [HRs] of SpA. Results During follow-up, 2,430 FDRs of IBD patients [6.5/10,000 person-years] and 17,761 FDRs of reference individuals [4.8/10,000 person-years] were diagnosed with SpA, corresponding to an HR of 1.35 [95%CI:1.29,1.41]. In subgroup analyses, the increased risk of SpA was most pronounced in FDRs of Crohn's disease patients [HR=1.44; 95%CI:1.34,1.56] and of IBD patients aged <18 years at diagnosis [HR=1.46; 95%CI: 1.27,1.68]. IBD patient’s spouses also had a higher SpA rate than reference individuals’ spouses, but the difference was less pronounced [4.3 vs. 3.5/10,000 person-years; HR=1.22; 95%CI:1.09,1.37]. No subgroup-specific risk pattern was identified among spouses. Conclusions The observed shared familial risks between IBD and SpA support shared genetic factors in their pathogenesis. However, spouses of IBD patients were also at increased risk for SpA, reflecting the influence of environmental exposures or similarities in health-seeking patterns.

gastroenterology & hepatology
Maintenance intravenous fluids with 0.9% sodium chloride do not produce hypernatraemia in children

M. Moritz,J. Ayus

DOI: https://doi.org/10.1111/j.1651-2227.2011.02535.x

2012-03-01

Acta Paediatrica

Abstract:The standard of care in paediatrics for over 50 years has been to administer hypotonic intravenous fluids (IVF) to children in need of IVF therapy (1). This recommendation has been largely based on the assumption that the sodium concentration in IVF should reflect that found in the diet of an otherwise healthy child (2). The flaw in this approach is that hospitalized children have numerous stimuli for arginine vasopressin production. The administration of hypotonic IVF, sodium plus potassium concentration of IVF <154 mEq ⁄ L, would predictably result in hyponatraemia from impaired free water excretion (3). In 2003, we pointed out the dangers of the routine administration of hypotonic IVF to hospitalized children as it had been associated with numerous cases of hyponatraemic encephalopathy, many of which resulted in death or permanent neurologic impairment (3,4). We suggested that 0.9% sodium chloride (NaCl), sodium concentration 154 mEq ⁄ L, be used in maintenance IVF with hypotonic IVF being reserved for patients with either hypernatraemia or ongoing urinary or extrarenal free water losses. A major criticism of our approach was the fear that 0.9% NaCl would result in hypernatraemia (5). Since our original recommendation, there have been 18 prospective studies in over 1000 children, demonstrating that hypotonic IVF result in a significant fall in serum sodium whereas 0.9% NaCl helps maintain serum sodium without producing hypernatraemia (6,7). At the time of our initial recommendation, we were careful not to extend our recommendations to the term and preterm neonate because of unique physiologic issues seen in this age group (3). In this issue of Acta Pediatrica, Balasubramanian et al. report on a double-blind, randomized and controlled trial involving term neonates with hyperbilirubinaemia. They compared the effect of 0.2% NaCl vs. 0.9% NaCl administered over 8 h on change in serum sodium (8). They found that 0.2% NaCl resulted in a 45% incidence of hyponatraemia (Na < 135 mEq ⁄ L) at 24 h compared to only 7% with 0.9% NaCl, resulting in an odds ratio of 13 for developing hyponatraemia with 0.2% NaCl. They also observed that the 0.9% NaCl group had a 40% incidence of hypernatraemia (Na > 145 mEq ⁄ L) compared to 12% for the 0.2% NaCl. Based on this, they concluded that 0.9% NaCl may not be appropriate for the term neonate. What the authors failed to appreciate though is that the patients enrolled in this study were hypernatraemic at the time of enrolment. There were no exclusion criteria for abnormal serum sodium, and hypernatraemic patients were included. The average serum sodium at the time of enrolment was 143 ± 6 mEq ⁄ L. The exact number of patients with hypernatraemia at enrolment was not reported, but three patients (7%) in the 0.9% NaCl group had severe hypernatraemia (>150 mEq ⁄ L) at the time of enrolment. In this study, 0.9% NaCl did not produce hypernatraemia but rather perpetuated it where pre-existing; 0.9% NaCl resulted in no real change in serum sodium over the 8 h, with a reported fall in serum sodium for the 0.9% NaCl group of )0.01 mmol ⁄ h; 0.9% NaCl does not produce hypernatraemia when used in the absence of a renal Invited Commentary for Karthik Balasubramanian et al. Isotonic versus hypotonic fluid supplementation in term neonates with severe hyperbilirubinemia – a double-blind, randomized, controlled trial, pages 236–241. Acta Pædiatrica ISSN 0803–5253

Toxicity of volcanic-ash leachate to a blue-green alga. Results of a preliminary bioassay experiment.

Sarcoidosis mortality in Sweden: a population-based cohort study

Heart failure in first‐ and second‐generation immigrants aged 18–54 years in Sweden: A national study

The risk of hemochromatosis among first- and second-generation immigrants: a cohort study of the total population in Sweden

Risk and predictors of heart failure in sarcoidosis in a population-based cohort study from Sweden

Cancer mortality by country of birth and cancer type in Sweden: A 25‐year registry‐based cohort study

COVID-19 mortality among immigrants by duration of residence in Sweden: a population-based cohort study

National retrospective registry survey on the epidemiology of sarcoidosis in Finland 2002-2022

Closer Scientific Contact with Czechoslovakia.

Melatonergic Drugs in Clinical Practice

Search for the Decays B_{s}

COVID-19: incidence and mortality in Sweden comparing all foreign-born to all Swedish-born individuals in different occupations in an unvaccinated cohort of year 2020

Bilayer bending elasticity measured by Fourier analysis of thermally excited surface undulations of flaccid vesicles

Identifying sarcoidosis trends using web search and real-world data in Sweden: a retrospective longitudinal study

Inflammatory plasma protein levels are elevated years before sarcoidosis diagnosis: a nested case-control study in Sweden

Mortality differentials by immigrant groups in Sweden: the contribution of socioeconomic position.

Metabolism and kinetics of the hypoglycemic agent glipizide in man--comparison with glibenclamide.

Menopausal hormone therapy and risk of sarcoidosis: a population-based nested case–control study in Sweden

Sarcoidosis and lymphoma mortality risk: An observational study from the Spanish National Registry

Spondyloarthritis in first-degree relatives and spouses of patients with inflammatory bowel disease: A nationwide population-based cohort study from Sweden

Maintenance intravenous fluids with 0.9% sodium chloride do not produce hypernatraemia in children